Survey of COVID-19 Infection

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05706064

Enrollment

200000

Registered

2023-01-31

Start date

2022-12-28

Completion date

2023-06-30

Last updated

2024-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, Infections

Brief summary

Using online questionnaires, we will obtain data regarding COVID-19 infection and treatment, including incidence rate, hospitalization rate, severity of the infection, medications, mortality rate, etc, in both hospital and communities after the change of disease control policy in China.

Interventions

None listed

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* N/A

Exclusion criteria

* N/A

Design outcomes

Primary

Measure	Time frame	Description
All-cause mortality	6 months	Quickly obtain the all-cause mortality in patients with COVID-19

Secondary

Measure	Time frame	Description
Incidence rate of COVID-19 infection	6 months	Incidence rate of COVID-19 infection
Medication for COVID-19 treatment	6 months	Any medication for COVID-19 treatment
Hospitalization rate due to COVID-19 infection	6 months	Hospitalization rate due to COVID-19 infection
Severity of COVID-19 infection	6 months	severity of the COVID-19 infection

Countries

China

Outcome results